Previous close | 0.0269 |
Open | 0.0265 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 0.0269 - 0.0269 |
52-week range | 0.0140 - 0.0400 |
Volume | |
Avg. volume | 1,741,618 |
Market cap | N/A |
Beta (5Y monthly) | 1.42 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces the appointment of three new advisors to its team. Joining the advisory board are Ken Nelson, known for his leadership in the MedTech space; Dr. Saumil R. Oza, MD, an experienced electrophysiologist from Ascension Medical Group; and Dave Braun, a strategic and customer-driven executive with over 40 years of experience working in startup and large company environments.
Acarix, a leader in advanced acoustic-based cardiac diagnostic devices today announces the CADScor® System has been added to the United States Federal Supply Schedule (FSS). The nationwide contract simplifies purchasing for the Veterans Health Administration and other federal agencies to efficiently source the CADScor System.